•  
  •  
 

Abstract

Decaffeinated green coffee and turmeric are recognized for their protective effects against hypertension (HTN) and diabetes mellitus (DM). Combining them into a functional drink, green coffee and turmeric (GCT), offers potential health benefits for managing these conditions. This study explored the bioactivity of GCT in HTN and DM through network biology, identifying intersecting protein targets and their roles in inflammation and glucose metabolism. Key proteins identified were AKT1, CCL2, CXCL8, IL-1β, and IL18. Molecular docking revealed that GCT compounds, particularly Cafestol, Chlorogenic Acid, Kahweol, Curcumin, and Desmethoxycurcumin, interacted strongly with AKT1 at its allosteric site, potentially inhibiting its activity. However, the interactions with other proteins were weak or nonexistent. Molecular dynamics simulations further validated these findings, showing that Cafestol, Chlorogenic Acid, and Kahweol exhibited stable interactions with AKT1 under physiological conditions, while Curcumin was unstable and displaced from the binding site. These results suggest that the protective effects of GCT against HTN and DM are mediated through the inhibition of AKT1, influencing pathways related to inflammation and glucose metabolism

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.